אביליפיי 10 מ"ג
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ARIPIPRAZOLE 10 MG
Available from:
BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED
ATC code:
N05AX12
Pharmaceutical form:
TABLETS
Administration route:
PER OS
Manufactured by:
BRISTOL-MYERS SQUIBB S.R.L, ITALY
Therapeutic group:
ARIPIPRAZOLE
Therapeutic indications:
Abilify is indicated for the treatment of schizophrenia. And for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.
Authorization date:
2010-02-01
